SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens.
about
Regulatory Role of IL-1R8 in Immunity and DiseaseHeterogeneity of the gut microbiome in mice: guidelines for optimizing experimental designGoblet Cell Derived RELM-β Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell ProliferationMyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium.Recent advances in adherence and invasion of pathogenic Escherichia coliHost-microbe interactions in the small bowelA novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection.Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury.The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor.Active Transport of Phosphorylated Carbohydrates Promotes Intestinal Colonization and Transmission of a Bacterial Pathogen.Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection.The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.Milk Fat Globule Membrane Supplementation in Formula Modulates the Neonatal Gut Microbiome and Normalizes Intestinal Development.The innate immune system and inflammatory bowel disease.Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection.Interleukin-37: a new molecular target for host-directed therapy of tuberculosis.The Helical Shape of Campylobacter jejuni Promotes In Vivo Pathogenesis by Aiding Transit through Intestinal Mucus and Colonization of Crypts.IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.Preventing Overheating: Tight Control of Gut Innate Immunity in Health and Disease.Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.Toll-like receptors: promising therapeutic targets for inflammatory diseases.Lactobacillus delbrueckii TUA4408L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli-induced inflammatory response in porcine intestinal epitheliocytes via Toll-like receptor-2 and 4.Gastroduodenal mucosal defense.Mouse Models for Campylobacter jejuni Colonization and Infection.Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection.Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses.The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis.Characterization of SIGIRR/IL-1R8 Homolog from Zebrafish Provides New Insights into Its Inhibitory Role in Hepatic Inflammation.Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.The Muc2 mucin coats murine Paneth cell granules and facilitates their content release and dispersion.Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative ColitisA peculiar case of Campylobacter jejuni attenuated aspartate chemosensory mutant, able to cause pathology and inflammation in avian and murine model animals
P2860
Q26752524-16C75AEE-4035-4272-BA95-2D7F2459A53CQ26795715-F597818C-2AE1-4ED7-84C7-635282C62A0EQ27318038-D2CB1E79-ED62-4FD2-AF03-DB10D8470617Q33693973-64320E1A-97DD-459B-8F8E-C7F0CA47DC19Q34429054-D8D4064C-83C5-4F00-AC33-89426E8185C7Q35121920-59F29C80-81CF-48C3-B317-E0FBE47AADE2Q35208160-F52ABB1D-6E54-4B5B-A4AC-18413BE60372Q35221790-5C91E78D-990F-4E3D-B81E-94BF955539CEQ35533302-2EFF68BA-0A08-45CE-9D3E-6A411ED40B3CQ35752378-1A46EA11-BC4C-4A1D-AB91-ABFA7734B2A5Q35833796-92AAE9B4-BEF9-426C-9572-922ED98BEFE0Q36133332-87E14ACF-041B-4A05-B6D7-EB3B17BDB51AQ36237164-90B241CD-8184-403C-983F-2DF72B693599Q37723925-0FF2C69F-CF73-41EA-BC16-DD22A08801B2Q38293766-24B2599B-E6A1-4D9F-9C2D-EBEAF6035B22Q38399710-DF371F2F-9446-4BBF-98AF-A6156574772CQ38686666-4918B526-58A4-4B9A-A097-DE776888A096Q38744822-E044FDB3-1017-483D-BD82-508AEEC67F97Q38856948-CBBC32AB-4AE8-480A-BEC8-58FCA184618CQ38857818-A0988151-09D9-46B5-A5D9-4F4D150884BFQ38920969-B1D52373-357C-4025-85BB-7FFBA21EB48CQ38925152-80C44526-DF64-4B08-AB3F-C373ACC4E1F0Q38978054-3B6EC05F-C67D-4F46-94ED-3A05E125436CQ39127799-0D6664D7-A615-4DF0-83A4-59474B15CD85Q40436393-95CE320F-A2F6-4781-8B8A-FF4B1114EAD6Q41602366-81AFB330-792B-4AE2-8650-4D9CF78DDE84Q42209211-7FFCCAF4-F705-4C65-86C7-2DDBA23D621AQ44698940-07A6B1D8-FE4F-466D-AC70-DF8BF9EFA8AFQ47073621-04E6EAB1-E257-4D8A-9831-7CBFBD83E654Q47285918-A19BCF32-4D0B-4C3C-B55E-332657C9084FQ52716494-F60D3D03-64B3-4695-819B-BCB2536054D2Q57490844-77E971A5-662B-40D8-8710-786EA84091DCQ58721870-ED34D8C5-984F-46A6-951D-95F20DF6BFC9
P2860
SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@ast
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@en
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@nl
type
label
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@ast
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@en
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@nl
prefLabel
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@ast
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@en
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@nl
P2093
P2860
P1433
P1476
SIGIRR, a negative regulator o ...... y enteric bacterial pathogens.
@en
P2093
Bruce A Vallance
Deanna L Gibson
Emily Yi Shan Yu
Ganive Bhinder
Ho Pan Sham
Justin M Chan
Kelly M McNagny
Lara Brewster
Martin Stahl
Michael R Hughes
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003539
P577
2013-08-08T00:00:00Z